Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 264

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 2
Chunk 264
---
3)
On July 13, 2023, the compensation committee of the Board of Directors of the Company reduced the exercise price of outstanding options
of employees and directors of the Company for the purchase of an aggregate of 2,947 shares of common stock of the Company (with exercise
prices of $208 per share) to $8.72 per share, which was the closing price for the Company’s common stock on July 13, 2023.

(4)
Consists of (i) 12,500 restricted shares with a grant date of September 29, 2022 and vesting in three equal installments on January
1, 2023, January 1, 2024, and January 1, 2025, and (ii) 37,500 restricted shares with a grant date of February 14, 2024 and
vesting in three equal installments on January 1, 2025, January 1, 2026, and January 1, 2027.

(5)
Consisting of (i) 3,000 restricted shares with a grant date of September 29, 2022 and vesting in three equal installments on January
1, 2023, January 1, 2024, and January 1, 2025, and (ii) 18,750 restricted share with a grant date of February 14, 2024 and
vesting in three equal installments on January 1, 2025, January 1, 2026, and January 1, 2027.

(6)
Consisting of (i) 3,000 restricted shares with a grant date of September 29, 2022 and vesting in three equal installments on January
1, 2023, January 1, 2024, and January 1, 2025, and (ii) 18,750 restricted shares with a grant date of February 14, 2024 and
vesting in three equal installments on January 1, 2025, January 1, 2026, and January 1, 2027.

53

Director
Compensation

The
following table sets forth compensation information for our non-employee directors for the year ended December 31, 2024.

    Name 
    Fees
    earned or paid in cash ($)(1)  
    Option
    awards ($)(1)(2)